Metraipolis › archive › dc_7e8c19dc2e14

Optimizing treatment for Waldenström macroglobulinemia-associated acquired von Willebrand syndrome: a case report and literature review — Europe PMC PMID:41982238

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41982238
DOI: 10.3389/fonc.2026.1766342
License (as archived): solo-consultazione
Archived: 2026-11-03T16:39:19.774Z
SHA-256 of the archived text: 74fbbb68eb6ece0f9fc5ee248c1ebf734a76cf8323c0d578deeb44e5653c1628
Stable URL of this page: https://metraipolis.com/documento/dc_7e8c19dc2e14

How to cite

Optimizing treatment for Waldenström macroglobulinemia-associated acquired von Willebrand syndrome: a case report and literature review — Europe PMC PMID:41982238 — Europe PMC (en), https://europepmc.org/article/MED/41982238 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e8c19dc2e14 (Metraipolis archive dc_7e8c19dc2e14, sha256 74fbbb68eb6ece0f9fc5ee248c1ebf734a76cf8323c0d578deeb44e5653c1628)

BibTeX

@misc{dc7e8c19dc2e14,
  title = {Optimizing treatment for Waldenström macroglobulinemia-associated acquired von Willebrand syndrome: a case report and literature review — Europe PMC PMID:41982238},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41982238},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e8c19dc2e14; sha256 74fbbb68eb6ece0f9fc5ee248c1ebf734a76cf8323c0d578deeb44e5653c1628},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41982238. Agents can read the archived copy with the MCP tool read_document.